MicroRNAs and human cancer

Experimental Oncology

Volumn 34, Issue 1, 2012, Pages 2-8

  Nikitina, E G ^a   Urazova, L N ^a   Stegny, V N ^b  

^a CANCER RESEARCH INSTITUTE   (Russian Federation)

^b TOMSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Human cancer; MicroRNA

Indexed keywords

MICRORNA; MICRORNA 124; MICRORNA 15A; MICRORNA 16; MICRORNA 21; MICRORNA 9;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; BREAST CANCER; CANCER PROGNOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MELANOMA; NEOPLASM; REVIEW; TREATMENT RESPONSE;

ANIMALS; CHROMOSOME ABERRATIONS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84862498321     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (102)

1. Lee RC, Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001; 294: 862-4. (Pubitemid 33032105)
2. Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-8. (Pubitemid 33032103)
3. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 14: 15-20. (Pubitemid 40094598)
4. Flynt AS, Lai EC. Biological principles of microRNAmediated regulation: shared themes amid diversity. Nat Rev Genet 2008; 9 : 831-42.
5. Stadler BM, Ruohola-Baker H. Small RNAs: keeping stem cells in line. Cell 2008; 132: 563-6. (Pubitemid 351255612)
6. Lodish HF, Zhou B, Liu G, et al. Micromanagement of the immune system by microRNAs. Nat Rev Immunol 2008; 8: 120-30. (Pubitemid 351161305)
7. Esquela-Kerscher A, Johnson SM, Bai L, et al. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-69.
8. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006; 25: 6188-96. (Pubitemid 44527849)
9. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-54. (Pubitemid 24014542)
10. Olsen PH, Ambros V. The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol 1999; 216: 671-80. (Pubitemid 30013313)
11. Johnson SM. Post-embryonic expression of C. elegans microRNAs belonging to the lin-4 and let-7 families in the hypodermis and the reproductive system. Dev Dyn 2005; 234: 868-77. (Pubitemid 41741159)
12. Pasquinelli AE, Reinhart BJ, Slack F. et al. Conservation across animal phylogeny of the sequence and temporal regulation of the 21 nucleotide let-7 heterochronic regulatory RNA. Nature 2000; 408: 86-9.
13. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nature 2004; 5: 522-31. (Pubitemid 38868508)
14. Grosshans H, Slack FJ. Micro-RNAs: small is plentiful. J Cell Biol 2002; 156: 17-22.
15. Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101: 2999-3004. (Pubitemid 38327724)
16. Kim VN. Small RNAs: classification, biogenesis, and function. Mol Cells 2005; 19: 1-15.
17. Gregory RI, Yan KP, Amuthan G. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004; 432: 235-40. (Pubitemid 39545855)
18. Denli AM, Tops B, Plasterk RH, et al. Processing of primary microRNAs by the Microprocessor complex. Nature 2004; 432: 231-35. (Pubitemid 39545854)
19. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 251-63.
20. Bohnsack MT, Czaplinski K, Gorlich D. Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs. RNA 2004; 10: 185-91. (Pubitemid 38129823)
21. Lund E, Guttinger S, Calado A, et al. Nuclear export of microRNA precursors. Science 2004; 303: 95-8. (Pubitemid 38055779)
22. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001; 409: 363-6. (Pubitemid 32151243)
23. Ketting RF, Fischer SE, Bernstein E, et al. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C.elegans. Genes Dev 2001; 15: 2654-9. (Pubitemid 32988876)
24. Hutvagner G, McLachlan J, Pasquinelli AE. A cellular function for the RNA-interference enzyme dicer in the maturation of the let-7 small temporal RNA. Science 2001; 293: 834-8. (Pubitemid 32743968)
25. Doench JG, Petersen CP, Sharp PA. siRNAs can function as miRNAs. Genes Dev 2003; 17: 438-42. (Pubitemid 36258757)
26. Song J-J, Smith SK, Hannon GJ, et al. Crystal structure of argonaute and its implications for RISC slicer activity. Science 2004; 305: 1434-7. (Pubitemid 39167656)
27. Ender C, Meister G. Argonaute proteins at a glance. J Cell Sci 2010; 123: 1819-23.
28. Yi R, Pasolli HA, Landthaler M. DGCR8-dependent microRNA biogenesis is essential for skin development. Proc Natl Acad Sci USA 2009; 106: 498-502.
29. Cheloufi S, Dos Santos CO, Chong MM. A dicerindependent miRNA biogenesis pathway that requires Ago catalysis. Nature 2010; 465: 584-9.
30. Yang JS, Maurin T, Robine N. Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis. Proc Natl Acad Sci USA 2010; 107: 15163-8.
31. Berezikov E, Chung WJ, Willis J. Mammalian mirtron genes. Mol Cell 2007; 28: 328-6.
32. Babiarz JE, Ruby JG, Wang Y, et al. Mouse ES cells express endogenous shRNAs, siRNAs, and other microprocessor-independent, Dicer-dependent small RNAs. Genes Dev 2008; 22: 773-85.
33. Xiang J, Wu J. Feud or friend? The role of the miR-17-92 cluster in tumorigenesis. Current Genomics 2010; 11: 129-35.
34. Davidson-Moncada J, Papavasiliou FN, Tam W. MicroRNAs of the immune system. Roles in inflammation and cancer. Ann NY Acad Sci USA 2010; 1183: 183-94.
35. Von Roretz C, Gallouzi IE. Decoding ARE mediated decay: is microRNA part of the equation? J Cell Biol 2008; 181: 189-94. (Pubitemid 351574545)
36. Peters L, Meister G. Argonaute proteins: mediators of RNA silencing. Mol Cell 2007; 26: 611-23. (Pubitemid 46856239)
37. Liu X, Chen Z, Yu G, et al. MicroRNA profiling and head and neck cancer. Comp Funct Genomics 2009; 52: 837-45.
38. Calin GA, Dumitry CD, Shimizu M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-9. (Pubitemid 35403967)
39. Volinia S, Calin GA, Liu CG. A microRNA expression signature of human solid tumors de.nes cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61. (Pubitemid 43271657)
40. He L, Thomson JM, Hemann MT. A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828-33. (Pubitemid 40839734)
41. O'Donnell KA, Wentzel EA, Zeller KI, et al. C-Mycregulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839-43. (Pubitemid 40839736)
42. Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628-32. (Pubitemid 41541436)
43. Xiang Jie, Wu J. The role of the miR-17-92 cluster in tumorigenesis. Current Genomics 2010; 11: 129-35.
44. Takamizawa J, Konishi H, Yanagisawa K, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753-6. (Pubitemid 38697282)
45. Kumar MS, Erkeland SJ, Pester RE. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 2008; 105: 3903-8. (Pubitemid 351723497)
46. Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86-90.
47. Krichevsky AM, Gabriely G. miR-21: a small multifaceted RNA. J Cell Mol Med 2009; 13: 39-53.
48. Jazbutyte V, Thum T. MicroRNA-21: from cancer to cardiovascular disease. Curr Drug Targets 2010; 11: 926-35.
49. Hurst DR, Edmonds MD, Welch DR. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 2009; 69: 7495-8.
50. Garzon R, Fabbri M, Cimmino A, et al. MicroRNA expression and function in cancer. Trends Mol Med 2006; 2: 580-7. (Pubitemid 44780201)
51. Croce C. MicroRNAs in leukemia. Clin Adv Hematol Oncol 2006; 4: 577-8. (Pubitemid 44430534)
52. Hammond SM. RNAi, microRNAs, and human disease. Cancer Chemother Pharmacol 2006; 58: 63-8.
53. Bottoni A, Piccin D, Tagliati F, et al. MiR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 2005; 204: 280-5. (Pubitemid 40776831)
54. Zhang L, Huang J, Yang N. MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 2006; 103: 9136-41. (Pubitemid 43902545)
55. Mavrakis KJ, Wolfe AL, Oricchio E. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 2010; 12: 372-9.
56. Gauwerky CE, Huebner K, Isobe M, et al. Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia. Proc Natl Acad Sci USA 1989; 86: 8867-71. (Pubitemid 20010326)
57. Osada H, Takahashi T. MicroRNAs in biological processes and carcinogenesis. Carcinogenesis 2007; 28: 2-12. (Pubitemid 44942621)
58. Hua Dong, Li Luo, Siu H, et al. Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma BMC. Systems Biology 2010; 4: 163-83.
59. Tagawa H, Seto M. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 2005; 19: 2013-6. (Pubitemid 41554018)
60. Starczynowski DT, Morin R, McPherson A, et al. Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood 2011; 117: 595-607.
61. Lv SQ, Kim YH, Giulio F, et al. Genetic alterations in microRNAs in medulloblastomas. Brain Pathol 2011; doi: 10.1111/j.1750-3639.2011.00523.
62. Kumar MS, Lu J, Golub TR, et al. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007; 39: 673-7. (Pubitemid 46676103)
63. Bernstein E, Kim SY, Carmell MA, et al. Dicer is essential for mouse development. Nat Genet 2003; 35: 215-7. (Pubitemid 37363172)
64. Wang Y, Medvid R, Melton C, et al. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 2007; 39: 380-5. (Pubitemid 46328490)
65. Lambertz I, Nittner D, Mestdagh P. Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo. Cell Death Differ 2010; 17: 633-41.
66. Kumar MS, Pester RE, Chen CY, et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 2009; 23: 2700-4.
67. Melo SA, Ropero S, Moutinho C, et al. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41: 365-70.
68. Shiohama A, Sasaki T, Noda S, et al. Molecular cloning and expression analysis of a novel gene DGCR8 located in the DiGeorge syndrome chromosomal region. Biochem Biophys Res Commun 2003; 304: 184-90. (Pubitemid 36434214)
69. Shuai Jiang, Hong-Wei Zhang, Lu MH, et al. MicroRNA-155 functions as an oncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 2010; 70: 3119-27.
70. Mayr C, Hemann MT, Bartel DP. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007; 315: 1576-9. (Pubitemid 46449474)
71. Mayr C, Bartel DP. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009; 138: 673-84.
72. Bhattacharyya SN, Habermacher R, Martine U, et al. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006; 125: 1111-24. (Pubitemid 43866197)
73. Kedde M, Strasser MJ, Boldajipour B, et al. RNAbinding protein Dnd1 inhibits microRNA access to target mRNA. Cell 2007; 131: 1273-86.
74. Kim HH, Kuwano Y, Srikantan S, et al. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 2009; 23: 1743-8.
75. Kedde M, van Kouwenhove M, Zwart W, et al. A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility. Nat Cell Biol 2010; 12: 1014-20.
76. Wutz A, Smrzka OW, Schweifer N, et al. Imprinted expression of the Igf2r gene depends on an intronic CpG island. Nature 1997; 389: 745-9. (Pubitemid 27458963)
77. Lyle R, Watanabe D, te Vruchte D, et al. The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1. Nat Genet 2000; 25: 19-21. (Pubitemid 30257030)
78. Scott GK, Mattie MD, Berger CE, et al. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 2006; 66: 1277-81. (Pubitemid 43259904)
79. Saito Y, Liang G, Egger G. Specific activation of microRNA- 127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9: 435-43. (Pubitemid 43832188)
80. Lehmann U, Hasemeier B, Christgen M, et al. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 2008; 214: 17-24.
81. Benetti R, Gonzalo S. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol 2008; 15: 268-79. (Pubitemid 351654050)
82. Noonan EJ, Place RF, Pookot D, et al. MiR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 2009; 28: 1714-24.
83. Braconi C, Huang N, Patel T. MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 2009; 51: 881-90.
84. Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008; 105: 3556-61.
85. Roman-Gomez J, Agirre X, Jimenez-Velasco A, et al. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. Clin Oncol 2009; 27: 1316-22.
86. Bandres E, Agirre X, Bitarte N, et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009; 125: 2737-43.
87. Wong KY, So CC, Loong F, et al. Inactivation of the miR-124-1 in haematological malignancies. PLoS One 2011; 6: e19027.
88. Toyota M, Suzuki H, Sasaki Y, et al. Epigenetic silencing of microRNA-34bc and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008; 68: 4123-32.
89. Kozaki K, Imoto I, Mogi S, et al. Exploration of tumorsuppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008; 68: 2094-105. (Pubitemid 351521781)
90. Bueno MJ, Perez de Castro I, Gymez de Cedryn M, et al. Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008; 13: 496-506.
91. Furuta M, Kozaki KI, Tanaka S, et al. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31: 766-76.
92. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11: 597-610.
93. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007; 129: 1401-14. (Pubitemid 46970709)
94. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-8. (Pubitemid 40839735)
95. Jiang J, Lee EJ, Gusev Y, et al. Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucl Acids Res 2005; 33: 5394-403. (Pubitemid 41548806)
96. Mydlarz WK, Hennessey PT, Califano JA. Advances and perspectives in the molecular diagnosis of head and neck cancer. Expert Opin Med Diagn 2010; 4: 53-65.
97. Ebert MS, Sharp PA. MicroRNA sponges: progress and possibilities. RNA 2010; 16: 2043-50.
98. Stefani G. Roles of microRNAs and their targets in cancer. Expert Opin Biol Ther 2007; 7: 1833-40. (Pubitemid 350252953)
99. Jackson AL, Linsley PS. Noise amidst the silence: offtarget effects of siRNAs? Trends Genet 2004; 20: 521-4. (Pubitemid 39314555)
100. Jackson AL, Burchard J, Schelter J. Widespread siRNA "off- target" transcript silencing mediated by seed region sequence complementarity. RNA 2006; 12: 1179-87. (Pubitemid 43990543)
101. Kovalchuk OV, Pogribny IP, Chekhun VF. UKR Conference "Molecular Basis and Clinical Problems of Drug Resistance", 2006. Ukraine. Abstract book. P. 3.
102. Meng F, Henson R, Lang M, et al. Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006; 130: 2113-29. (Pubitemid 43816961)